Lupin Limited has informed the Exchange regarding a press release dated September 06, 2023, titled "Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundationto Expand Access to Medication for COPD Patients.".
Lupin Limited has informed the Exchange regarding a press release dated September 06, 2023, titled "Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundationto Expand Access to Medication for COPD Patients.".